PGIM India Healthcare Growth Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

PGIM India Healthcare Growth Direct Plan

NAV
₹9.6800
-2.71%
(13 Jan)
Risk
Very High Risk
Insights
No insights found for this fund
Compare with other fund
1Y
+25.5%
+19.4%
+17.4%
+14.4%
NA
3Y
+28.7%
+30.2%
+28.5%
+29.9%
NA
5Y
+27.8%
+26.7%
+28.2%
+23.3%
NA
ALL
+17.7%
+16.9%
+17.2%
+11.4%
-3.2%
VOL
18.6%
19.6%
18.1%
20.3%
15.0%
TER
0.8%
0.8%
1.2%
0.7%
NA
AUM
₹5,515 Cr
₹1,286 Cr
₹6,911 Cr
₹4,572 Cr
NA
INFO
0.95
0.86
0.95
0.56
-0.21
See fund holdings as of 31st Dec
Top holdings
Sun Pharmaceuticals Industries Ltd
13.5%
Divi's Laboratories Ltd
7.5%
Max Healthcare Institute Ltd Ordinary Shares
7.0%
Dr Reddy's Laboratories Ltd
6.5%
Mankind Pharma Ltd
4.8%
Aster DM Healthcare Ltd Ordinary Shares
4.0%
Clearing Corporation Of India Ltd.
3.9%
Torrent Pharmaceuticals Ltd
3.7%
Krishna Institute of Medical Sciences Ltd
3.4%
Syngene International Ltd
3.0%
Top industry exposure
Healthcare
87.0%
Financial Services
4.5%
Basic Materials
1.7%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Fund manager(s)
Puneet Pal
Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma

FAQs